We believe we have an important role and responsibility in improving access to medicines, vaccines and quality health care worldwide, helping to reduce the burden of disease in the parts of the world that need it most.
We work in collaboration with local communities, governments, donors, patient organizations, health care professionals, nongovernmental organizations (NGOs), multilateral organizations, and others in the private sector to contribute our expertise and knowledge.
The programs highlighted below are examples of our ongoing efforts.
ACS: Global Patient Navigation
Through a $2 million grant over five years (2019–2023), our company’s Foundation is helping the American Cancer Society (ACS) bring its expertise and experience in patient navigation to countries with a growing burden of cancer. This partnership aims to improve patient support and access to cancer care in sub-Saharan Africa and develop guidance to help low- and middle-income countries adopt similar models of care. Learn more.
Addressing the Opioid Crisis in West Virginia
Our company’s Foundation is supporting a new initiative with Marshall Health through a $2 million grant over four years (2018–2021) to establish the Great Rivers Regional System for Addiction Care—a comprehensive program to address the opioid crisis in West Virginia. Learn more.
Alliance to Advance Patient-Centered Cancer Care
In 2017, our company’s Foundation launched the Alliance to Advance Patient-Centered Cancer Care. The Alliance aims to increase timely access to patient-centered care and reduce disparities in cancer care, especially for vulnerable and underserved populations in the United States. Learn more.
Bridging the Gap: Reducing Disparities in Diabetes Care
Our company’s Foundation launched Bridging the Gap in 2017 to improve access to high-quality diabetes care and to reduce health disparities among vulnerable and underserved populations with type 2 diabetes in the United States. Learn more.
Improving Alzheimer’s Care in the U.S.
In 2018, our company’s Foundation launched several new programs that aim to improve the health and well-being of vulnerable individuals living with Alzheimer’s and their caregivers in the United States. Learn more.
MECTIZAN® Donation Program
The MECTIZAN® (ivermectin) Donation Program is the longest-running disease-specific drug donation program and public-private partnership of its kind, and is widely regarded as one of the most successful public-private health collaborations in the world. Learn more.
Medical Outreach Program
Our company’s Medical Outreach Program was established in 1958. It is the primary mechanism through which our company donates its pharmaceuticals and vaccines for humanitarian assistance in the developing world and in support of disaster relief and emergency situations worldwide. Learn more.
MSD for Mothers
MSD for Mothers is a 10-year, $500 million initiative focused on improving the health and well-being of mothers before, during and after pregnancy and childbirth.
Working together with committed partners, we believe we can help make pregnancy and childbirth a safe, healthy and joyful experience for women. Learn more.
To help build health care capacity and expand access to specialty care for complex or chronic conditions among underserved populations in Asia, our company’s Foundation established a new partnership with Project ECHO (Extension for Community Healthcare Outcomes) to expand the replication of Project ECHO in India and Vietnam. Learn more.
U.S. Patient Assistance Programs
More than 55 years ago, our company created our first U.S. patient assistance program (PAP) to keep affordable medicines within patients’ reach. Today, our patient assistance offerings include several programs. Learn more.
The programs highlighted below are examples of our past programs and initiatives.
African Comprehensive HIV/AIDS Partnerships
Together with our company’s Foundation and the Bill & Melinda Gates Foundation, we established the African Comprehensive HIV/AIDS Partnerships (ACHAP) in 2002 to support Botswana, a country disproportionately affected by HIV/AIDS. Learn more.
For lessons from ACHAP’s contributions to the fight against HIV/AIDS in Botswana, click here.
Alliance to Reduce Disparities in Diabetes
To address the growing problem of health care disparities related to type 2 diabetes in the U.S. among low-income and underserved adult populations, our company’s Foundation launched the Alliance to Reduce Disparities in Diabetes, with a commitment of $15 million. Learn more.
China-MSD HIV/AIDS Partnership
Our company’s Foundation committed $36 million to establish the China-MSD HIV/AIDS Partnership (C-MAP). C-MAP was the first large-scale public-private partnership between the Chinese government and a multinational company to focus on HIV/AIDS prevention and control. Learn more.
HIV Care Collaborative
In 2012, to help address remaining barriers to HIV care, especially among underserved populations, our company’s Foundation launched the HIV Care Collaborative for Underserved Populations in the U.S. with the goal of connecting more people living with HIV to the care they need to stay healthy. Learn more.
GARDASIL® Access Program
Through the GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] Access Program, we pledged to donate at least 3 million doses of GARDASIL for use in smaller-scale human papillomavirus (HPV) vaccination projects in eligible lowest-income countries around the world. Learn more.
MCAN, a U.S.-based organization established in 2005, was the only private foundation focused solely on addressing the complex and growing problem of childhood asthma within the United States. MCAN’s mission was to enhance the quality of life of children with asthma and their families, and to reduce the burden of the disease on them and on society. This program concluded in 2015.